Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 24Other hematologic neoplasm 18Gastrointestinal 18Thoracic 12Gynecologic 11Tumor-Agnostic 10Lymphoid 8Genitourinary 8Other solid neoplasm 6CNS 6Plasma cell 5Sarcoma 4Head & Neck 4Myeloid 3Dermatologic 3Endocrine 2Other 1NET 1

Conditions

Weight Loss 1Obesity 1Neuroendocrine Tumors 1Multiple Endocrine Neoplasia Type 1 1

Interventions

Everolimus 59lutetium Lu 177 dotatate 46Magnetic Resonance Spectroscopy 33pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 24lanreotide 23cabozantinib 22pasireotide 21gallium Ga 68 dotatate 21lenvatinib 20Etoposide 19Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18Sunitinib 17Bevacizumab 16trametinib 15dabrafenib 15Doxorubicin 143-Iodobenzylguanidine 14surufatinib 13Sorafenib 13Ipilimumab 13Thyrotropin Alfa 12Injections 12Positron Emission Tomography Computed Tomography 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Palliative Care × Endocrine × Clear all
NCT01849523 2024-05-06

WIN

University Medical Center Groningen

Phase NA Completed
20 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT02938897 2016-10-19

Telenutrition Weight Loss Study for Men

West Virginia University

Phase NA Completed
60 enrolled
EndocrineOther

Obesity, Weight Loss, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡